Clinical trial
Adjuvant Capecitabine in Elderly Patients With Breast Cancer: a Phase II Study
NCT00263705 · Jules Bordet Institute, Other · Completed
Key facts
| NCT number | NCT00263705 |
|---|---|
| Title | Adjuvant Capecitabine in Elderly Patients With Breast Cancer: a Phase II Study |
| Official title | Adjuvant Capecitabine in Elderly Patients With Breast Cancer: a Phase II Study |
| Lead sponsor | Jules Bordet Institute, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Elderly Patients, Breast Cancer |
| Intervention type | Drug |
| Interventions | Adjuvant capecitabine, capecitabine in aduvant setting |
| Enrollment | 43 |
| Start date | Jan 1, 2003 |
| Primary completion | Aug 1, 2009 |
| Completion | Aug 1, 2009 |
| First posted | Dec 9, 2005 |
| Last update posted | Feb 24, 2011 |
| Countries | Belgium |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: